Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
SSMXY SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS
30.540
-0.700-2.24%
YOY
Do not show
Hide blank lines
(Q2)2022/09/30(Q1)2022/06/30(FY)2022/03/31(Q4)2022/03/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
12.11% 165.0946 12.87% 169.5643 7.35% 154.9877 7.35% 154.9877
Receivable Turnover(T)
-6.83% 3.6751 -9.33% 3.5861 1.28% 3.3171 1.28% 3.3171
Inventory Turnover(T)
-6.11% 2.8992 -4.89% 2.7944 0.49% 3.18 0.49% 3.18
Fixed Assets Turnover(T)
9.09% 3.9429 10.25% 3.7427 18.21% 3.7375 18.21% 3.7375
Total Asset Rate(T)
-1.70% 0.8144 -0.54% 0.8125 6.89% 0.7985 6.89% 0.7985
ROIC
-5.53% 12.459% -3.64% 11.883% 19.26% 12.660% 19.26% 12.660%
ROE
-6.48% 13.118% -4.58% 12.549% 18.72% 13.439% 18.72% 13.439%
ROA
-6.73% 9.662% -4.80% 9.280% 19.26% 9.678% 19.26% 9.678%
FCF to Sales
-74.35% 3.411% -65.22% 3.941% -32.18% 7.341% -32.18% 7.341%
FCF to Net Income
-72.96% 28.752% -63.67% 34.504% -39.21% 60.567% -39.21% 60.567%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -8.94% 14.275% -- --
ROA 5 Year Average
-- -- -- -- -8.94% 10.527% -- --
Average 5 Years ROIC
-- -- -- -- -10.08% 13.789% -- --
Profitability Ratios TTM
Gross Margin
-1.00% 51.228% 1.22% 51.737% 3.58% 52.390% 3.58% 52.390%
Operating Margin
-9.72% 17.303% -7.03% 17.189% 9.16% 18.533% 9.16% 18.533%
Net Margin
-5.12% 11.864% -4.28% 11.421% 11.57% 12.121% 11.57% 12.121%
EBITDA Margin
-4.06% 0.2519% -2.90% 0.2492% 4.37% 0.2548% 4.37% 0.2548%
R & D Expense Ratio
7.01% 7.630% 6.73% 7.610% -0.27% 7.360% -0.27% 7.360%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
3.90% 26.400% 2.37% 26.360% -2.26% 25.900% -2.26% 25.900%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-6.82% 4.403% -8.75% 4.650% -13.45% 4.548% -13.45% 4.548%
Total Assets to Common Equity
-1.78% 134.638% -0.88% 134.684% 0.03% 138.875% 0.03% 138.875%
Debt to Asset Ratio
-2.88% 6.289% -5.01% 6.588% -10.32% 6.396% -10.32% 6.396%
Current Ratio
5.22% 2.8893 5.15% 2.8805 4.96% 2.6948 4.96% 2.6948
Quick Ratio
-2.09% 1.9167 -2.10% 1.8697 1.55% 1.8999 1.55% 1.8999
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- 178.42% 7.417% -- --
Revenue CAGR(5Y)
-- -- -- -- 105.17% 7.799% -- --
Net Income CAGR(3Y)
-- -- -- -- 141.53% 2.267% -- --
Net Income CAGR(5Y)
-- -- -- -- 193.14% 1.646% -- --
Dividend CAGR(3Y)
-- -- -- -- -92.72% 0.267% -- --
Dividend CAGR(5Y)
-- -- -- -- -7.39% 5.465% -- --
FCF 1 Year Growth
-- -- -- -- -180.95% -19.125% -- --
FCF CAGR(3Y)
-- -- -- -- 154.49% 19.206% -- --
FCF CAGR(5Y)
-- -- -- -- 31.04% 14.238% -- --
Currency Unit
JPYJPYJPYJPY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
CEO: Mr. Hisashi Ietsugu
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist